Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Williams

Showing results (301-310 of 331) with videos related to

Pageof 34
Sort By:
Journal of the American College of Cardiology|March 11, 2026
Single-Ventricle Disease: Long-Term Outcomes and Global Morbidity in the Single Ventricle Reconstruction TrialKevin D Hill, Lillian Kang, Qiao Wang, et al.
Nature|December 15, 2006
An SCN9A channelopathy causes congenital inability to experience painJames J Cox, Frank Reimann, Adeline K Nicholas, et al.
The American Journal of Cardiology|July 21, 2009
Comparison of echocardiographic and cardiac magnetic resonance imaging measurements of functional single ventricular volumes, mass, and ejection fraction (from the Pediatric Heart Network Fontan Cross-Sectional Study)Renee Margossian, Marcy L Schwartz, Ashwin Prakash, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2012
Discovery and SAR of a novel series of non-MPEP site mGlu₅ PAMs based on an aryl glycine sulfonamide scaffoldAlice L Rodriguez, Ya Zhou, Richard Williams, et al.
Annals of the Rheumatic Diseases|December 16, 2018
Targeting early changes in the synovial microenvironment: a new class of immunomodulatory therapy?Susan R Aungier, Alison J Cartwright, Anja Schwenzer, et al.
Current Topics in Medicinal Chemistry|October 8, 2009
Discovery and development of a potent and highly selective small molecule muscarinic acetylcholine receptor subtype I (mAChR 1 or M1) antagonist in vitro and in vivo probeC David Weaver, Douglas J Sheffler, L Michelle Lewis, et al.
Journal of Medicinal Chemistry|January 17, 2024
The Discovery of Exarafenib (KIN-2787): Overcoming the Challenges of Pan-RAF Kinase InhibitionYoung K Chen, Toufike Kanouni, Lee D Arnold, et al.
The New England Journal of Medicine|September 13, 2013
Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancerJean-Yves Douillard, Kelly S Oliner, Salvatore Siena, et al.
Molecular Pharmacology|December 3, 2008
Discovery and characterization of novel allosteric potentiators of M1 muscarinic receptors reveals multiple modes of activityJoy E Marlo, Colleen M Niswender, Emily L Days, et al.
Molecular Pharmacology|July 31, 2008
Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4Colleen M Niswender, Kari A Johnson, C David Weaver, et al.
Pageof 34

Showing results (301-310 of 331) with videos related to

Sort By:
Pageof 34
Journal of the American College of Cardiology|March 11, 2026
Single-Ventricle Disease: Long-Term Outcomes and Global Morbidity in the Single Ventricle Reconstruction TrialKevin D Hill, Lillian Kang, Qiao Wang, et al.
Nature|December 15, 2006
An SCN9A channelopathy causes congenital inability to experience painJames J Cox, Frank Reimann, Adeline K Nicholas, et al.
The American Journal of Cardiology|July 21, 2009
Comparison of echocardiographic and cardiac magnetic resonance imaging measurements of functional single ventricular volumes, mass, and ejection fraction (from the Pediatric Heart Network Fontan Cross-Sectional Study)Renee Margossian, Marcy L Schwartz, Ashwin Prakash, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2012
Discovery and SAR of a novel series of non-MPEP site mGlu₅ PAMs based on an aryl glycine sulfonamide scaffoldAlice L Rodriguez, Ya Zhou, Richard Williams, et al.
Annals of the Rheumatic Diseases|December 16, 2018
Targeting early changes in the synovial microenvironment: a new class of immunomodulatory therapy?Susan R Aungier, Alison J Cartwright, Anja Schwenzer, et al.
Current Topics in Medicinal Chemistry|October 8, 2009
Discovery and development of a potent and highly selective small molecule muscarinic acetylcholine receptor subtype I (mAChR 1 or M1) antagonist in vitro and in vivo probeC David Weaver, Douglas J Sheffler, L Michelle Lewis, et al.
Journal of Medicinal Chemistry|January 17, 2024
The Discovery of Exarafenib (KIN-2787): Overcoming the Challenges of Pan-RAF Kinase InhibitionYoung K Chen, Toufike Kanouni, Lee D Arnold, et al.
The New England Journal of Medicine|September 13, 2013
Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancerJean-Yves Douillard, Kelly S Oliner, Salvatore Siena, et al.
Molecular Pharmacology|December 3, 2008
Discovery and characterization of novel allosteric potentiators of M1 muscarinic receptors reveals multiple modes of activityJoy E Marlo, Colleen M Niswender, Emily L Days, et al.
Molecular Pharmacology|July 31, 2008
Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4Colleen M Niswender, Kari A Johnson, C David Weaver, et al.
Pageof 34